Simone Gana

Medicine & Life Sciences

1. Phenotype 100%
2. Agenesis of Cerebellar Vermis 87%
3. Genes 77%
4. Haploinsufficiency 70%
5. Microcephaly 67%
6. Exome 66%
7. Otofaciocervical Syndrome 64%
8. Transfer RNA 60%
9. Intellectual Disability 59%
10. Polyps 56%
11. Brain Diseases 56%
12. Epilepsy 52%
13. Hereditary Nonpolyposis Colorectal Neoplasms 48%
14. Cerebellar Hypoplasia 48%
15. Retinal Dystrophies 47%
16. Periventricular Nodular Heterotopia 46%
17. Ataxia 45%
18. Adenomatous Polyposis Coli 45%
19. Myoclonic dystonia 44%
20. Pseudouridine 44%
21. Smith-Lemli-Opitz Syndrome 44%
22. Mutation 40%
23. Cyclin-Dependent Kinase 5 40%
24. Metaplasia 40%
25. Cerebral Amyloid Angiopathy 38%
26. Presenilin-1 38%
27. Polyneuropathies 37%
28. Dysphonia 35%
29. High-Throughput Nucleotide Sequencing 35%
30. Italy 33%
31. Neurodevelopmental Disorders 32%
32. Congenital Heart Defects 32%
33. CDKL5 deficiency disorder 31%
34. Codon 31%
35. Movement Disorders 30%
36. Genotype 29%
37. Apraxia, oculomotor, Cogan type 28%
38. Turcot syndrome 27%
39. Peutz-Jeghers Syndrome 27%
40. Pediatrics 26%
41. Atypical Rett Syndrome 25%
42. Dystonic Disorders 25%
43. Cost-Benefit Analysis 23%
44. Myoclonus 23%
45. Cognitive Dysfunction 22%
46. Anhidrotic Ectodermal Dysplasia 1 22%
47. Paris 22%
48. Whole Exome Sequencing 21%
49. Muscle Hypotonia 21%
50. ADP-Ribosylation Factors 21%